Mangoceuticals Income Statement (2023-2026) | MGRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.10M0.14M0.25M0.24M0.21M0.16M0.13M0.11M0.11M0.17M0.08M0.09M0.07M
Cost of Revenue (Quarter) 0.02M0.03M0.05M0.05M0.02M0.03M0.02M0.02M0.02M0.02M0.00M0.01M0.01M
Gross Profit (Quarter) 0.06M0.09M0.14M0.14M0.15M0.07M0.08M0.08M0.06M0.09M0.05M0.05M0.03M
Operating items
Selling, General & Administrative (Quarter) 1.05M
Amortization - Intangibles (Quarter) 0.28M0.28M
Other Operating Expenses (Quarter) 2.10M
Operating Expenses (Quarter) 3.16M
Operating Income (Quarter) -3.13M
EBIT (Quarter) -3.13M
Non-operating items
Other Non Operating Income (Quarter) -0.13M0.11M
Non Operating Income (Quarter) -0.28M
Net income details
EBT (Quarter) -3.40M
Profit After Tax (Quarter) -3.40M
Income from Non-Controlling Interests (Quarter) -0.00M
Income from Continuing Operations (Quarter) -3.40M
Consolidated Net Income (Quarter) -3.40M
Income towards Parent Company (Quarter) -3.40M
Preferred Dividend Payments (Quarter) 0.29M
Net Income towards Common Stockholders (Quarter) -3.70M
Additional items
EPS (Basic) (Quarter) -0.22
EPS (Weighted Average and Diluted) (Quarter) -0.22
Shares Outstanding (Weighted Average) (Quarter) 16.48M
Shares Outstanding (Diluted Average) (Quarter) 16.48M
EBITDA (Quarter) -3.40M
Interest Expenses (Quarter) -0.01M0.02M0.08M0.02M